Login to Your Account



Inverseon, CBio Combine Programs in All-Stock Merger

By Marie Powers
Staff Writer

Wednesday, September 5, 2012
Australian drug developer CBio Ltd. acquired privately held Inverseon Inc. in an all-stock deal, creating Invion Ltd., which will operate from offices in San Francisco and Brisbane.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription